
Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(11), P. 1517 - 1517
Published: Nov. 11, 2024
Over the past few decades, extended-spectrum β-lactamase (ESBL)-producing bacteria have become a great concern in healthcare systems worldwide, imposing large burdens by increasing antimicrobial resistance and patient morbidity. Given high mortality rates emergence of multidrug-resistant (MDR) strains, monitoring ESBL prevalence patterns is crucial. This study aimed to evaluate ESBL-producing
Language: Английский